CLINICAL RESEARCH ON ANTIANGIOGENIC THERAPY

A promising novel target for anti-cancer therapy is the tumour vasculature. Both primary tumour growth and the formation of metastasis depend on the establishment of new blood vessels from preexisting ones, a process called angiogenesis. Inhibition of angiogenesis and targeting of the tumour vascula...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmacological research 1998-01, Vol.37 (1), p.1-16
Hauptverfasser:	KUIPER, R.A.J., SCHELLENS, J.H.M., BLIJHAM, G.H., BEIJNEN, J.H., VOEST, E.E.
Format:	Artikel
Sprache:	eng
Schlagworte:	angiogenesis, cancer, pharmacology, clinical trials, design Antibodies - therapeutic use Antineoplastic Agents - therapeutic use Basement Membrane - drug effects Clinical Trials as Topic Endothelium, Vascular - drug effects Humans Neoplasms - secretion Neoplasms - therapy Neovascularization, Pathologic - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A promising novel target for anti-cancer therapy is the tumour vasculature. Both primary tumour growth and the formation of metastasis depend on the establishment of new blood vessels from preexisting ones, a process called angiogenesis. Inhibition of angiogenesis and targeting of the tumour vasculature are highly effective in controlling tumour growth. Several natural and synthetic compounds have been developed and are currently tested in pre-clinical and clinical studies. This review intends to provide an overview of agents with antiangiogenic activity and the early clinical experience with these drugs.
ISSN:	1043-6618 1096-1186
DOI:	10.1006/phrs.1997.0268